engleski

Successful intraosseous therapy using EZ-IO system in a preterm neonate below 2 kg

Although EZ-IO system is cleared by U.S. Food and Drug Administration for patients weighing more than 3 kg, we demonstrated successful use of this system in a preterm infant below 2 kg. In our patient the EZ-IO needle insertion procedure was a life-saving event, it enabled us to administer appropriate therapy and proved to be safe and effective. Therefore, we advise the use of EZ-IO system in all patients, including preterm neonates, in whom it is vital to administer therapy as soon as possible.

intraosseous ; EZ-IO system ; preterm neonate

nije evidentirano